Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-pheno
about
Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data.Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against Staphylococcus aureus.Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model.RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections.Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinationsMacrophage adaptation leads to parallel evolution of genetically diverse Escherichia coli small-colony variants with increased fitness in vivo and antibiotic collateral sensitivity.Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia.Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones.Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review.Oritavancin: a long-acting antibacterial lipoglycopeptide.Nonstable Staphylococcus aureus Small-Colony Variants Are Induced by Low pH and Sensitized to Antimicrobial Therapy by Phagolysosomal Alkalinization.Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections.Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections.Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis.Altered Competitive Fitness, Antimicrobial Susceptibility, and Cellular Morphology in a Triclosan-Induced Small-Colony Variant of Staphylococcus aureus.Evolution of Staphylococcus aureus under vancomycin selective pressure: the role of the small-colony variant phenotype.In Vitro Susceptibility of Clinical Staphylococcus aureus Small Colony Variants to β-Lactam and Non-ß-Lactam Antibiotics.Escape from growth restriction in small colony variants of Salmonella typhimurium by gene amplification and mutation.In vivo activity of oritavancin in animal infection models and rationale for a new dosing regimen in humans.Influence of the protein kinase C activator phorbol myristate acetate on the intracellular activity of antibiotics against hemin- and menadione-auxotrophic small-colony variant mutants of Staphylococcus aureus and their wild-type parental strain in h
P2860
Q30597709-FDB57B58-BE0D-4B00-84CE-275E44FF0679Q34528916-F48F3A8A-B41D-4CD1-A290-BCCB5F5FDF18Q34737534-7020A497-6E18-4586-B3B0-5ADE78B28C93Q35860120-B8FAE603-44A8-4315-AE4D-634B4E46730AQ36675223-1ACC0596-0BF6-4BF0-902E-58235ED7CB05Q37144883-0A6B5973-1C29-4618-956B-5BC7A6B8B508Q37208314-282E915F-5972-4C6A-AF24-A87E9768121DQ37955286-11FA623A-A7B7-41CF-AD01-475404B51FBFQ38233471-C6384276-C7EB-4839-9E49-97D7121273E7Q38646905-AAF61289-32DC-4048-B5A2-F75F31930C21Q38830176-C1A707FC-D80D-4D08-BA14-5027B9052923Q38851656-90659353-8D17-400C-ABFB-CA0D60321CA5Q39031276-02D1932B-51FF-4EBF-9FF1-C398568E6991Q39352419-C2736940-9917-4B08-895D-D61107953B3CQ40901796-4718318F-5412-4342-AD35-CE80F3890505Q41190866-92D8FB4D-D15D-4B13-9596-C9DD5EEB6130Q41883337-BE948C5F-5577-4F8D-9ECF-C9DC19A9B267Q48148232-6107AB13-DD20-40D7-BCBD-8C0EF371B2A0Q50044240-0BFE3EDC-5FF5-42BD-BF4F-14AB32477815Q51760113-D9C53C28-0242-47CC-85D8-0EF3BD1FF75EQ58573611-462BF3B0-4092-4044-B361-8F675BEE9150
P2860
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-pheno
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intracellular activity of anti ...... son with isogenic normal-pheno
@en
Intracellular activity of anti ...... son with isogenic normal-pheno
@nl
type
label
Intracellular activity of anti ...... son with isogenic normal-pheno
@en
Intracellular activity of anti ...... son with isogenic normal-pheno
@nl
prefLabel
Intracellular activity of anti ...... son with isogenic normal-pheno
@en
Intracellular activity of anti ...... son with isogenic normal-pheno
@nl
P2093
P2860
P921
P356
P1476
Intracellular activity of anti ...... henotype and revertant strains
@en
P2093
Anne Theunis
Anne Vergison
Hoang Anh Nguyen
Marc J Struelens
Olivier Denis
P2860
P304
P356
10.1128/AAC.01145-08
P407
P577
2009-02-02T00:00:00Z